GLOBE LIFE INC.·4

May 6, 4:05 PM ET

Darden James Matthew 4

4 · GLOBE LIFE INC. · Filed May 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Globe Life (GL) CEO James Darden Exercises Options, Sells Shares

What Happened

  • James Matthew Darden, Co‑Chairman, CEO and a director of Globe Life (GL), exercised 22,019 options on May 5, 2026 at $100.74 per share (total exercise cost $2,218,194) and the filing shows he sold the 22,019 shares the same day in two open‑market transactions. The sales were 12,905 shares at a weighted price reported around $153.53 (proceeds $1,981,334) and 9,114 shares at about $154.29 (proceeds $1,406,203). Total sale proceeds ≈ $3,387,537, implying gross proceeds minus exercise cost of ≈ $1,169,343.

Key Details

  • Transaction date: 2026-05-05; filing date: 2026-05-06 (timely filing).
  • Option exercise (code M): 22,019 shares acquired at $100.74 ($2,218,194).
  • Sales (code S): 12,905 shares at prices in the $153.00–$153.95 range (proceeds $1,981,334); 9,114 shares at prices in the $154.00–$154.64 range (proceeds $1,406,203). Combined sales ≈ $3,387,537.
  • Footnotes: F1 notes the reporting person will provide per‑trade share counts on request; F2/F3 give the price ranges for the two sale blocks.
  • Shares owned after the transactions: not specified in the provided filing.

Context

  • This is an exercise of derivative awards followed by immediate open‑market sales — effectively a cashless exercise (exercised options converted to shares then sold).
  • Exercise (M) and sale (S) are routine forms of insider liquidity and do not by themselves indicate future company performance. The filing was submitted promptly the next day.

Insider Transaction Report

Form 4
Period: 2026-05-05
Darden James Matthew
DirectorCo-Chairman & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-05$100.74/sh+22,019$2,218,19480,470.46 total
  • Sale

    Common Stock

    [F1][F2]
    2026-05-05$153.53/sh12,905$1,981,33467,565.46 total
  • Sale

    Common Stock

    [F1][F3]
    2026-05-05$154.29/sh9,114$1,406,20358,451.46 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2026-05-0522,0190 total
    Exercise: $100.74From: 2023-02-26Exp: 2027-02-26Common Stock (22,019 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    4,194.479
Footnotes (3)
  • [F1]Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
  • [F2]Sales at prices ranging from $153.00 per share to $153.95 per share.
  • [F3]Sales at prices ranging from $154.00 per share to $154.64 per share.
Signature
J. Matthew Darden by /s/ Chris T. Moore, Attorney- in-Fact|2026-05-06

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES